| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |